100%
Skip to main content
Platform
GovTribe AI
AI-powered insights to accelerate your government contracting workflow.
MCP Server
Connect GovTribe to your AI tools.
Beacon
Find and connect with key government decision-makers.
Profiles
Federal Agencies
Federal Contract Vehicles
Federal Grant Programs
Major Defense Acquisition Programs
NAICS Categories
PSC Categories
States
Jurisdictions
NIGP Categories
UNSPSC Categories
Vendors
Enrichment By Clearbit
Reports
New Entrants
Funding Analysis
Vehicle Analysis
Groups
Capture
Pipelines
Pursuits
Alerts
Teaming
Data
Awards
Forecasts
Federal Opportunities
State & Local Opportunities
Files
Prime and Subcontractors
Activity
Search
Exports
Solutions
Use Case
Opportunity Identification
Capture Management
Competitive Intelligence
Teaming & Partner Identification
Proposal Management
Strategic Leadership
Go-to-Market Strategy
Industry
Federal Contractors
State & Local Contractors
Grant Seekers
Government Agencies
Research & Consulting
Pricing
More
About Us
Features
Get A Demo
Sign Up
Blog
User Guide
Data Model
GovTribe for Agents
Login
Contact sales
Try for free
Login
Contact sales
Try for free
All Federal Grant Awards
Project Grant R44AI122405
Award Date
3/1/16
Completion Date
12/31/22
Dollars Obligated
$1.9M
Overview
Activity
4
Transactions
4
Subawards
Similar Awards
Federal Agency
National Institute of Allergy and Infectious Diseases
Awardee
Brighton Development (RYCEB8HU2U77)
Federal Grant Program
93.855
Assistance Type
Project Grant
Place of Performance
Cary, NC 27513, USA
Update #1
Update #2
NOVEL LOW TEMPERATURE STERILIZATION METHOD FOR FLEXIBLE ENDOSCOPES
Posted 1/10/20
5
1
Mod #
Description
ReasonForModification
Federal Obligation
Date
Not listed
NOVEL LOW TEMPERATURE STERILIZATION METHOD FOR FLEXIBLE ENDOSCOPES - ABSTRACT HEALTHCARE-ASSOCIATED INFECTIONS (HAI) ARE THE SINGLE LARGEST PREVENTABLE MEDICAL COST IN TERMS OF BOTH ECONOMIC AND HUMANITARIAN COST. THE MAJOR SIGNIFICANCE OF THIS PROBLEM IS REFLECTED IN THE $35-BILLION ANNUAL EXPENDITURE MADE FOR HEALTHCARE ASSOCIATED INFECTIONS IN THE MEDICAL COMMUNITY. DUE TO THE LARGE NUMBER OF PROCEDURES DONE EACH YEAR, ENDOSCOPES ARE ASSOCIATED WITH MORE HAI OUTBREAKS AND CLUSTERS THAN ANY OTHER SINGLE MEDICAL DEVICE. THE MAJORITY OF HEALTHCARE ASSOCIATED INFECTIONS FROM ENDOSCOPES RESULT FROM THE FAILURE OF PERSONNEL TO COMPLY WITH COMPLICATED AND TEDIOUS REPROCESSING DISINFECTION PROCEDURES. THIS RECURRING PROBLEM TO FOLLOW PROPER DISINFECTION PROCEDURES HAS CREATED A NEED FOR AN ENDOSCOPE STERILIZATION PROCESS THAT WILL IMPROVE COMPLIANCE WITH REPROCESSING PROCEDURES WITH A FAST, INEXPENSIVE METHOD TO STERILIZE NARROW LUMENS IN MEDICAL DEVICES. RECENT STUDIES HAVE DOCUMENTED THAT PATIENT-TO-PATIENT HAI TRANSMISSION COULD OCCUR EVEN WITH PROPERLY REPROCESSED AND DISINFECTED ENDOSCOPES. STERILIZATION OF SMALL DIAMETER CONDUITS IN MEDICAL DEVICES SUCH AS ENDOSCOPES, CATHETERS, AND TUBING HAS PLAGUED THE MEDICAL INDUSTRY FOR YEARS. ALONG THESE LINES, THERE HAS BEEN AN EXPLOSION OF NEW MINIMALLY INVASIVE SURGICAL TECHNIQUES IN RECENT YEARS USING VARIOUS ENDOSCOPIC DEVICES THAT CONTAIN LONG LUMENS THAT ARE EXTREMELY DIFFICULT TO STERILIZE USING TRADITIONAL METHODS. THESE EXPENSIVE DEVICES OFTEN CONTAIN HEAT SENSITIVE GLUES, OPTICS, OR ELECTRONICS THAT WILL NOT TOLERATE AUTOCLAVE OR HEAT ASSOCIATED WITH RE-STERILIZATION IN THE MEDICAL ENVIRONMENT. BRIGHTON DEVELOPMENT SUCCESSFULLY MET ALL THE FEASIBILITY GOALS OF PHASE I THAT RESULTED IN THE DEVELOPMENT OF AN INNOVATIVE METHOD FOR STERILIZING ENDOSCOPES AND OTHER NARROW LUMEN DEVICES. THE SAFE EFFICIENT METHOD USES OUR NOVEL STERILANT- RELEASING INSERT TO ACHIEVE QUICK STERILIZATION OF HEAT SENSITIVE SURGICAL DEVICES SUCH AS EXPENSIVE ENDOSCOPES. THE STERILIZING INSERT METHOD DEVELOPED IN PHASE I IS SIMPLE, SAFE, AND ECONOMICAL AND WILL IMPROVE PATIENT CARE WITH A HIGH LEVEL OF STERILITY THAT IS VERIFIABLE AND EASY-TO-USE COMPARED TO THE CUMBERSOME DISINFECTION CLEANING METHODS CURRENTLY USED IN HOSPITALS. IN OCTOBER 2018 WE RECEIVED US PATENT # 10,092,667, WHICH COVERS THE CORE STERILANT TECHNOLOGY THAT WILL BE USED FOR THE LOW TEMPERATURE INSIDE-OUT STERILIZATION OF ENDOSCOPES. UNDER THE LOW TEMPERATURE CONDITIONS, THIS PROCESS WILL NOT DAMAGE THE HEAT-SENSITIVE MATERIALS USED TO FABRICATE ENDOSCOPES. IN PHASE II, WE WILL DEVELOP THE REQUIRED BACKUP DATA TO MEET THE FDA REQUIREMENTS TO COMMERCIALIZE THIS INSIDE-OUT STERILIZATION METHOD FOR ENDOSCOPES USING THE DUODENOSCOPE AS THE MODEL. THE SPECIFIC AIMS AND COMMERCIALIZATION PLAN, HEREIN, OUTLINE IN DETAIL THE FDA STEPS REQUIRED TO ACHIEVE THE SUCCESSFUL INTRODUCTION OF THIS TECHNOLOGY INTO THE MARKETPLACE USING THE SIMPLE INSIDE-OUT STERILIZATION METHOD, WHICH WAS PROVEN FEASIBLE IN PHASE I.
$0
11/6/23
Not listed
NOVEL LOW TEMPERATURE STERILIZATION METHOD FOR FLEXIBLE ENDOSCOPES - ABSTRACT HEALTHCARE-ASSOCIATED INFECTIONS (HAI) ARE THE SINGLE LARGEST PREVENTABLE MEDICAL COST IN TERMS OF BOTH ECONOMIC AND HUMANITARIAN COST. THE MAJOR SIGNIFICANCE OF THIS PROBLEM IS REFLECTED IN THE $35-BILLION ANNUAL EXPENDITURE MADE FOR HEALTHCARE ASSOCIATED INFECTIONS IN THE MEDICAL COMMUNITY. DUE TO THE LARGE NUMBER OF PROCEDURES DONE EACH YEAR, ENDOSCOPES ARE ASSOCIATED WITH MORE HAI OUTBREAKS AND CLUSTERS THAN ANY OTHER SINGLE MEDICAL DEVICE. THE MAJORITY OF HEALTHCARE ASSOCIATED INFECTIONS FROM ENDOSCOPES RESULT FROM THE FAILURE OF PERSONNEL TO COMPLY WITH COMPLICATED AND TEDIOUS REPROCESSING DISINFECTION PROCEDURES. THIS RECURRING PROBLEM TO FOLLOW PROPER DISINFECTION PROCEDURES HAS CREATED A NEED FOR AN ENDOSCOPE STERILIZATION PROCESS THAT WILL IMPROVE COMPLIANCE WITH REPROCESSING PROCEDURES WITH A FAST, INEXPENSIVE METHOD TO STERILIZE NARROW LUMENS IN MEDICAL DEVICES. RECENT STUDIES HAVE DOCUMENTED THAT PATIENT-TO-PATIENT HAI TRANSMISSION COULD OCCUR EVEN WITH PROPERLY REPROCESSED AND DISINFECTED ENDOSCOPES. STERILIZATION OF SMALL DIAMETER CONDUITS IN MEDICAL DEVICES SUCH AS ENDOSCOPES, CATHETERS, AND TUBING HAS PLAGUED THE MEDICAL INDUSTRY FOR YEARS. ALONG THESE LINES, THERE HAS BEEN AN EXPLOSION OF NEW MINIMALLY INVASIVE SURGICAL TECHNIQUES IN RECENT YEARS USING VARIOUS ENDOSCOPIC DEVICES THAT CONTAIN LONG LUMENS THAT ARE EXTREMELY DIFFICULT TO STERILIZE USING TRADITIONAL METHODS. THESE EXPENSIVE DEVICES OFTEN CONTAIN HEAT SENSITIVE GLUES, OPTICS, OR ELECTRONICS THAT WILL NOT TOLERATE AUTOCLAVE OR HEAT ASSOCIATED WITH RE-STERILIZATION IN THE MEDICAL ENVIRONMENT. BRIGHTON DEVELOPMENT SUCCESSFULLY MET ALL THE FEASIBILITY GOALS OF PHASE I THAT RESULTED IN THE DEVELOPMENT OF AN INNOVATIVE METHOD FOR STERILIZING ENDOSCOPES AND OTHER NARROW LUMEN DEVICES. THE SAFE EFFICIENT METHOD USES OUR NOVEL STERILANT- RELEASING INSERT TO ACHIEVE QUICK STERILIZATION OF HEAT SENSITIVE SURGICAL DEVICES SUCH AS EXPENSIVE ENDOSCOPES. THE STERILIZING INSERT METHOD DEVELOPED IN PHASE I IS SIMPLE, SAFE, AND ECONOMICAL AND WILL IMPROVE PATIENT CARE WITH A HIGH LEVEL OF STERILITY THAT IS VERIFIABLE AND EASY-TO-USE COMPARED TO THE CUMBERSOME DISINFECTION CLEANING METHODS CURRENTLY USED IN HOSPITALS. IN OCTOBER 2018 WE RECEIVED US PATENT # 10,092,667, WHICH COVERS THE CORE STERILANT TECHNOLOGY THAT WILL BE USED FOR THE LOW TEMPERATURE INSIDE-OUT STERILIZATION OF ENDOSCOPES. UNDER THE LOW TEMPERATURE CONDITIONS, THIS PROCESS WILL NOT DAMAGE THE HEAT-SENSITIVE MATERIALS USED TO FABRICATE ENDOSCOPES. IN PHASE II, WE WILL DEVELOP THE REQUIRED BACKUP DATA TO MEET THE FDA REQUIREMENTS TO COMMERCIALIZE THIS INSIDE-OUT STERILIZATION METHOD FOR ENDOSCOPES USING THE DUODENOSCOPE AS THE MODEL. THE SPECIFIC AIMS AND COMMERCIALIZATION PLAN, HEREIN, OUTLINE IN DETAIL THE FDA STEPS REQUIRED TO ACHIEVE THE SUCCESSFUL INTRODUCTION OF THIS TECHNOLOGY INTO THE MARKETPLACE USING THE SIMPLE INSIDE-OUT STERILIZATION METHOD, WHICH WAS PROVEN FEASIBLE IN PHASE I.
$469.7k
2/17/21
Not listed
NOVEL LOW TEMPERATURE STERILIZATION METHOD FOR FLEXIBLE ENDOSCOPES - ABSTRACT HEALTHCARE-ASSOCIATED INFECTIONS (HAI) ARE THE SINGLE LARGEST PREVENTABLE MEDICAL COST IN TERMS OF BOTH ECONOMIC AND HUMANITARIAN COST. THE MAJOR SIGNIFICANCE OF THIS PROBLEM IS REFLECTED IN THE $35-BILLION ANNUAL EXPENDITURE MADE FOR HEALTHCARE ASSOCIATED INFECTIONS IN THE MEDICAL COMMUNITY. DUE TO THE LARGE NUMBER OF PROCEDURES DONE EACH YEAR, ENDOSCOPES ARE ASSOCIATED WITH MORE HAI OUTBREAKS AND CLUSTERS THAN ANY OTHER SINGLE MEDICAL DEVICE. THE MAJORITY OF HEALTHCARE ASSOCIATED INFECTIONS FROM ENDOSCOPES RESULT FROM THE FAILURE OF PERSONNEL TO COMPLY WITH COMPLICATED AND TEDIOUS REPROCESSING DISINFECTION PROCEDURES. THIS RECURRING PROBLEM TO FOLLOW PROPER DISINFECTION PROCEDURES HAS CREATED A NEED FOR AN ENDOSCOPE STERILIZATION PROCESS THAT WILL IMPROVE COMPLIANCE WITH REPROCESSING PROCEDURES WITH A FAST, INEXPENSIVE METHOD TO STERILIZE NARROW LUMENS IN MEDICAL DEVICES. RECENT STUDIES HAVE DOCUMENTED THAT PATIENT-TO-PATIENT HAI TRANSMISSION COULD OCCUR EVEN WITH PROPERLY REPROCESSED AND DISINFECTED ENDOSCOPES. STERILIZATION OF SMALL DIAMETER CONDUITS IN MEDICAL DEVICES SUCH AS ENDOSCOPES, CATHETERS, AND TUBING HAS PLAGUED THE MEDICAL INDUSTRY FOR YEARS. ALONG THESE LINES, THERE HAS BEEN AN EXPLOSION OF NEW MINIMALLY INVASIVE SURGICAL TECHNIQUES IN RECENT YEARS USING VARIOUS ENDOSCOPIC DEVICES THAT CONTAIN LONG LUMENS THAT ARE EXTREMELY DIFFICULT TO STERILIZE USING TRADITIONAL METHODS. THESE EXPENSIVE DEVICES OFTEN CONTAIN HEAT SENSITIVE GLUES, OPTICS, OR ELECTRONICS THAT WILL NOT TOLERATE AUTOCLAVE OR HEAT ASSOCIATED WITH RE-STERILIZATION IN THE MEDICAL ENVIRONMENT. BRIGHTON DEVELOPMENT SUCCESSFULLY MET ALL THE FEASIBILITY GOALS OF PHASE I THAT RESULTED IN THE DEVELOPMENT OF AN INNOVATIVE METHOD FOR STERILIZING ENDOSCOPES AND OTHER NARROW LUMEN DEVICES. THE SAFE EFFICIENT METHOD USES OUR NOVEL STERILANT- RELEASING INSERT TO ACHIEVE QUICK STERILIZATION OF HEAT SENSITIVE SURGICAL DEVICES SUCH AS EXPENSIVE ENDOSCOPES. THE STERILIZING INSERT METHOD DEVELOPED IN PHASE I IS SIMPLE, SAFE, AND ECONOMICAL AND WILL IMPROVE PATIENT CARE WITH A HIGH LEVEL OF STERILITY THAT IS VERIFIABLE AND EASY-TO-USE COMPARED TO THE CUMBERSOME DISINFECTION CLEANING METHODS CURRENTLY USED IN HOSPITALS. IN OCTOBER 2018 WE RECEIVED US PATENT # 10,092,667, WHICH COVERS THE CORE STERILANT TECHNOLOGY THAT WILL BE USED FOR THE LOW TEMPERATURE INSIDE-OUT STERILIZATION OF ENDOSCOPES. UNDER THE LOW TEMPERATURE CONDITIONS, THIS PROCESS WILL NOT DAMAGE THE HEAT-SENSITIVE MATERIALS USED TO FABRICATE ENDOSCOPES. IN PHASE II, WE WILL DEVELOP THE REQUIRED BACKUP DATA TO MEET THE FDA REQUIREMENTS TO COMMERCIALIZE THIS INSIDE-OUT STERILIZATION METHOD FOR ENDOSCOPES USING THE DUODENOSCOPE AS THE MODEL. THE SPECIFIC AIMS AND COMMERCIALIZATION PLAN, HEREIN, OUTLINE IN DETAIL THE FDA STEPS REQUIRED TO ACHIEVE THE SUCCESSFUL INTRODUCTION OF THIS TECHNOLOGY INTO THE MARKETPLACE USING THE SIMPLE INSIDE-OUT STERILIZATION METHOD, WHICH WAS PROVEN FEASIBLE IN PHASE I.
$469.7k
2/17/21
Not listed
NOVEL LOW TEMPERATURE STERILIZATION METHOD FOR FLEXIBLE ENDOSCOPES
$521.9k
1/10/20